• 1
    Hillenkamp, F. (1989) Laser radiation tissue interaction. Health Phys. 56, 613616.
  • 2
    Jacques, S. L. (1997) Laser-tissue interactions. In Non-Ionizing Radiation: An Overview of the Physics and Biology (Edited by K. Hardy, M. Meltz and R. D. Glickman), pp. 8198. Medical Physics Publishing, Madison,WI.
  • 3
    Glickman, R. D. (2002) Phototoxicity to the retina: Mechanisms of damage. Int. J. Toxicol. 21, 473490.
  • 4
    Sliney, D. H. (2005) Exposure geometry and spectral environment determine photobiological effects on the human eye. Photochem. Photobiol. 81, 483489.
  • 5
    Taylor, H. R., B. Munos, S. West, N. M. Bressler, S. B. Bressler and F. S. Rosenthal (1990) Visible light and risk of age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 88, 163178.
  • 6
    Tomany, S. C., K. J. Cruickshanks, R. Klein, B. E. Klein and M. D. Knudtson (2004) Sunlight and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Arch. Ophthalmol. 122, 750757.
  • 7
    Cabrera, M. P. and R. H. Chihuailaf (2011) Antioxidants and the integrity of ocular tissues. Vet. Med. Int. 2011, 905153 (pp. 1–8).
  • 8
    Kelsey, N. A., H. M. Wilkins and D. A. Linseman (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules 15, 77927814.
  • 9
    Baur, J. A. and D. A. Sinclair (2006) Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5, 493506.
  • 10
    Das, D. K. and N. Maulik (2006) Resveratrol in cardioprotection: A therapeutic promise of alternative medicine. Mol. Interv. 6, 3647.
  • 11
    Gehm, B. D., J. M. McAndrews, P. Y. Chien and J. L. Jameson (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl Acad. Sci. USA 94, 1413814143.
  • 12
    Klinge, C. M., K. E. Risinger, M. B. Watts, V. Beck, R. Eder and A. Jungbauer (2003) Estrogenic activity in white and red wine extracts. J. Agric. Food Chem. 51, 18501857.
  • 13
    Turner, R. T., G. L. Evans, M. Zhang, A. Maran and J. D. Sibonga (1999) Is resveratrol an estrogen agonist in growing rats? Endocrinology 140, 5054.
  • 14
    Basly, J. P., F. Marre-Fournier, J. C. Le Bail, G. Habrioux and A. J Chulia (2000) Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci. 66, 769777.
  • 15
    Sato, M., G. Maulik, D. Bagchi and D. K. Das (2000) Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin. Free Radic. Res. 32, 135144.
  • 16
    Sato, M., P. S. Ray, G. Maulik, N. Maulik, R. M. Engelman, A. A. Bertelli, A. Bertelliand and D. K. Das (2000) Myocardial protection with red wine extract. J. Cardiovasc. Pharmacol. 35, 263268.
  • 17
    Shigematsu, S., S. Ishida, M. Hara, N. Takahashi, H. Yoshimatsu, T. Sakata and R. J. Korthuis (2003) Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic. Biol. Med. 34, 810817.
  • 18
    Losa, G. A. (2003) Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. Eur. J. Clin. Invest. 33, 818823.
  • 19
    Yen, G. C., P. D. Duh and C. W. Lin (2003) Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic. Res. 37, 509514.
  • 20
    Ahmad, A., F. A. Syed, S. Singh and S. M. Hadi (2005) Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA. Toxicol. Lett. 159, 112.
  • 21
    Gatz, S. A. and L. Wiesmuller (2008) Take a break—Resveratrol in action on DNA. Carcinogenesis 29, 321332.
  • 22
    Roemer, K. and M. Mahyar-Roemer (2002) The basis for the chemopreventive action of resveratrol. Drugs Today (Barc) 38, 571580.
  • 23
    Ali, M. S., S. A. Ibrahim, S. Jalil and M. I. Choudhary (2007) Ursolic acid: A potent inhibitor of superoxides produced in the cellular system. Phytother. Res. 21, 558561.
  • 24
    Najid, A., A. Simon, J. Cook, H. Chable-Rabinovitch, C. Delage, A. J. Chulia and M. Rigaud (1992) Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett. 299, 213217.
  • 25
    Yin, M. C. and K. C. Chan (2007) Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J. Agric. Food Chem. 55, 71777181.
  • 26
    Balanehru, S. and B. Nagarajan (1991) Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem. Int. 24, 981990.
  • 27
    Shishodia, S., S. Majumdar, S. Banerjee and B. B. Aggarwal (2003) Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63, 43754383.
  • 28
    Mohan, S., K. Koyoma, A. Thangasamy, H. Nakano, R. D. Glickman and N. Mohan (2007) Low shear stress preferentially enhances IKK activity through selective sources of ROS for persistent activation of NF-kappaB in endothelial cells. Am. J. Physiol. Cell Physiol. 292, C362C371.
  • 29
    Pahl, H. L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 68536866.
  • 30
    Raju, U., G. J. Gumin and P. J. Tofilon (2000) Radiation-induced transcription factor activation in the rat cerebral cortex. Int. J. Radiat. Biol. 76, 10451053.
  • 31
    Vile, G. F., A. Tanew-Ilitschew and R. M. Tyrrell (1995) Activation of NF-kappa B in human skin fibroblasts by the oxidative stress generated by UVA radiation. Photochem. Photobiol. 62, 463468.
  • 32
    Li, N. and M. Karin (1998) Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl Acad. Sci. USA 95, 1301213017.
  • 33
    Glickman, R. D., M. Natarajan, B. A. Rockwell, M. Denton, S. Maswadi, N. Kumar and F. Nieves-Roldan (2005) Intracellular signaling mechanisms responsive to laser-induced photochemical and thermal stress. In Optical Interactions with Tissue and Cells XVI (Edited by S. L. Jacques and W. P. Roach), Proc. SPIE 5695, 260269.
  • 34
    Legrand-Poels, S., S. Schoonbroodt, J. Y. Matroule and J. Piette (1998) NF-kappa B: An important transcription factor in photobiology. J. Photochem. Photobiol. B, Biol 45, 18.
  • 35
    Yim, E. K., K. H. Lee, S. E. Namkoong, S. J. Um and J. S. Park (2006) Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells. Cancer Lett. 235, 209220.
  • 36
    Yim, E. K., M. J. Lee, K. H. Lee, S. J. Um and J. S. Park (2006) Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines. Int. J. Gynecol. Cancer 16, 20232031.
  • 37
    Huang, M. T., C. T. Ho, Z. Y. Wang, T. Ferraro, Y. R. Lou, K. Stauber, W. Ma, C. Georgiadis, J. D. Laskin and A. H. Conney (1994) Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54, 701708.
  • 38
    Tokuda, H., H. Ohigashi, K. Koshimizu and Y. Ito (1986) Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett. 33, 279285.
  • 39
    De Angel, R. E., S. M. Smith, R. D. Glickman, S. N. Perkins and S. D. Hursting (2010) Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr. Cancer 62, 10741086.
  • 40
    Trela, B. C. and A. L. Waterhouse (1996) Resveratrol: Isomeric molar absorptivities and stability. J. Agric. Food Chem. 44, 12531257.
  • 41
    Jayatilake, G. S., H. Jayasuriya, E. S. Lee, N. M. Koonchanok, R. L. Geahlen, C. L. Ashendel, J. L. McLaughlin and C. J. Chang (1993) Kinase inhibitors from Polygonum cuspidatum. J. Nat. Prod. 56, 18051810.
  • 42
    Galeano-Diaz, T., I. Duran-Meras and D. Airado-Rodriguez (2007) Isocratic chromatography of resveratrol and piceid after previous generation of fluorescent photoproducts: Wine analysis without sample preparation. J. Sep. Sci. 30, 31103119.
  • 43
    Dontsov, A. E., R. D. Glickman and M. A. Ostrovsky (1999) Retinal pigment epithelium pigment granules stimulate the photo-oxidation of unsaturated fatty acids. Free Radic. Biol. Med. 26, 14361446.
  • 44
    Rambhatla, L., C. P. Chiu, R. D. Glickman and C. Rowe-Rendleman (2002) In vitro differentiation capacity of telomerase immortalized human RPE cells. Invest. Ophthalmol. Visual. Sci. 43, 16221630.
  • 45
    Natarajan, M., B. K. Nayak, C. Galindo, S. P. Mathur, F. N. Roldan and M. L. Meltz (2006) Nuclear translocation and DNA-binding activity of NFKB (NF-kappaB) after exposure of human monocytes to pulsed ultra-wideband electromagnetic fields (1 kV/cm) fails to transactivate kappaB-dependent gene expression. Radiat. Res. 165, 645654.
  • 46
    Glickman, R. D., M. Vendal, M. A. Gonzales and N. Kumar (1999) Intracellular photochemical reactions in the RPE cell exhibit a wavelength dependence that resembles the action spectrum of melanin. In Laser-Tissue Interaction X: Photochemical, Photothermal, and Photomechanical (Edited by S. L. Jacques), Proc. SPIE 3601 , 94101.
  • 47
    Glickman, R. D. (2011) Ultraviolet phototoxicity to the retina. Eye Contact Lens 37, 196205.
  • 48
    Mainster, M. A. and P. L. Turner (2010) Ultraviolet-B phototoxicity and hypothetical photomelanomagenesis: Intraocular and crystalline lens photoprotection. Am. J. Ophthalmol. 149, 543549.
  • 49
    Birrell, M. A., K. McCluskie, S. Wong, L. E. Donnelly, P. J. Barnes and M. G. Belvisi (2005) Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 19, 840841.
  • 50
    Chen, G., W. Shan, Y. Wu, L. Ren, J. Dong and Z. Ji (2005) Synthesis and anti-inflammatory activity of resveratrol analogs. Chem. Pharm. Bull. (Tokyo) 53, 15871590.
  • 51
    Elmali, N., I. Esenkaya, A. Harma, K. Ertem, Y. Turkoz and B. Mizrak (2005) Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm. Res. 54, 158162.
  • 52
    Rahman, I., S. K. Biswas and P. A. Kirkham (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72, 14391452.
  • 53
    Porcu, M. and A. Chiarugi (2005) The emerging therapeutic potential of sirtuin-interacting drugs: From cell death to lifespan extension. Trends Pharmacol. Sci. 26, 94103.
  • 54
    Anekonda, T. S. and G. Adamus (2008) Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res. Notes 1, 122.
  • 55
    Shindler, K. S., E. Ventura, T. S. Rex, P. Elliott and A. Rostami (2007) SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48, 36023609.
  • 56
    Luna, C., G. Li, P. B. Liton, J. Qiu, D. L. Epstein, P. Challa and P. Gonzalez (2009) Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem. Toxicol. 47, 198204.
  • 57
    Kim, Y. H., Y. S. Kim, S. S. Kang, G. J. Cho and W. S. Choi (2010) Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina. Diabetes 59, 18251835.
  • 58
    Baffy, G., Z. Derdak and S. C. Robson (2011) Mitochondrial recoupling: A novel therapeutic strategy for cancer? Br. J. Cancer 105, 469474.
  • 59
    Liao, Q., W. Yang, Y. Jia, X. Chen, Q. Gao and K. Bi (2005) LC-MS determination and pharmacokinetic studies of ursolic acid in rat plasma after administration of the traditional Chinese medicinal preparation Lu-Ying extract. Yakugaku Zasshi 125, 509515.